Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DEI07S
|
|||
| Drug Name |
AIP-303
|
|||
| Drug Type |
Radiopharmaceutical therapy agent
|
|||
| Indication | Breast cancer [ICD-11: 2C60-2C65; ICD-10: C50, C79.51] | Phase 1 | [1] | |
| Company |
Advanced Innovative Partners
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04469127) A Study of AIP-303 in HER2 Positive Breast Cancer and/or Metastatic Breast Cancer Patients (Heroine01). U.S. National Institutes of Health. | |||
| REF 2 | Clinical pipeline report, company report or official report of Adagene. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.